What’s in a name?
Inspired by Science. Driven by Strategy.
Cade Group was founded to answer a critical gap in biotech: most companies wait too long to define their competitive position. By the time strategy is addressed, the market is already crowded and the window to differentiate has closed.
Cade Group is named after the Australian psychiatrist Dr. John Cade (1912-1980), who, through serendipity and curiosity, discovered lithium as the first effective treatment for bipolar disorder. Lithium, while never patented, is considered one of the most effective mood stabilizers in psychiatric medicine and one of the most important discoveries in modern medicine.
We are not affiliated with Dr. Cade or his estate; our name honors the spirit of his discovery.
What Sets Us Apart
Research-Driven Positioning
Science, clinical design, and commercial strategy are aligned from the start.
Early Differentiation
We embed strategy from the very first stages of development — when it has the greatest impact.
Integrated Expertise
Every recommendation is grounded in data, market intelligence, and clinical insight.
CNS and Rare Disease Focus
Deep expertise in some of the most competitive and complex therapeutic areas.
Boutique, Senior-Led
You work directly with seasoned consultants, not junior layers or hand-offs.